ED70.4

ICD-11 MMS 2026-01

Anagen effluvium

Description

Anagen effluvium occurs after any insult to the hair follicle that impairs its mitotic or metabolic activity. Patients present with diffuse hair loss after an exposure to drugs or toxic chemicals. Chemotherapeutic agents are most commonly responsible for hair loss. The most severe hair loss occurs in association with doxorubicin, the nitrosoureas, and cyclophosphamide. Hair loss usually begins 7-14 days after a single pulse of chemotherapy. The hair loss is clinically most apparent after 1-2 months.

Index terms

  • Anagen effluvium
  • Anagen effluvium due to toxins or poisons

Foundation children elsewhere

  • EH72.01 – Drug-induced anagen effluvium

Sibling codes

  • ED70.0 – Male pattern hair loss
  • ED70.1 – Female pattern hair loss
  • ED70.2 – Alopecia areata
  • ED70.3 – Telogen effluvium
  • ED70.5 – Scarring alopecia
  • ED70.Y – Other specified alopecia or hair loss
  • ED70.Z – Alopecia, unspecified

Foundation entity

Anagen effluvium – http://id.who.int/icd/entity/597448549

Part of: ED70: Alopecia or hair loss › 14: Diseases of the skin